Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


23.04.2018

1 Abdom Radiol (NY)
1 Ann Diagn Pathol
1 Biomed Pharmacother
1 Biosci Rep
1 BMJ Open
2 Cancer
1 Cancer Causes Control
1 Cancer Radiother
1 CMAJ
1 Drug Des Devel Ther
1 EBioMedicine
1 Gene
1 J Cancer Res Clin Oncol
1 J Geriatr Oncol
3 J Urol
1 Med Sci Monit
1 Medicine (Baltimore)
1 Oncol Rep
1 Oncotarget
1 Prog Urol
1 Radiologe
1 Scand J Urol
1 Talanta
1 Technol Cancer Res Treat
1 Toxicol Sci
5 Urol Clin North Am
1 Urologe A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Abdom Radiol (NY)

  1. AREVALO N, Mendez R, Barrera J
    "Inchworm sign" in urinary bladder cancer.
    Abdom Radiol (NY). 2018 Apr 19. pii: 10.1007/s00261-018-1614.
    PubMed     Text format    


    Ann Diagn Pathol

  2. AGRAWAL U, Kumari N, Vasudeva P, Mohanty NK, et al
    Overexpression of COX2 indicates poor survival in urothelial bladder cancer.
    Ann Diagn Pathol. 2018;34:50-55.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  3. AN Q, Zhou L, Xu N
    Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143.
    Biomed Pharmacother. 2018;103:415-420.
    PubMed     Text format     Abstract available


    Biosci Rep

  4. YANG H, Li G, Cheng B, Jiang R, et al
    ZFAS1 functions as an oncogenic long noncoding RNA in bladder cancer.
    Biosci Rep. 2018 Apr 20. pii: BSR20180475. doi: 10.1042/BSR20180475.
    PubMed     Text format     Abstract available


    BMJ Open

  5. HE Y, Wang N, Zhou X, Wang J, et al
    Prognostic value of ki67 in BCG-treated non-muscle invasive bladder cancer: a meta-analysis and systematic review.
    BMJ Open. 2018;8:e019635.
    PubMed     Text format     Abstract available


    Cancer

  6. JAZZAR U, Yong S, Klaassen Z, Huo J, et al
    Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.
    Cancer. 2018 Apr 16. doi: 10.1002/cncr.31404.
    PubMed     Text format     Abstract available

  7. CORREA AF, Smaldone MC
    Melancholia and cancer: The bladder cancer narrative.
    Cancer. 2018 Apr 16. doi: 10.1002/cncr.31402.
    PubMed     Text format    


    Cancer Causes Control

  8. JOCHEMS SHJ, van Osch FHM, Reulen RC, van Hensbergen M, et al
    Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study.
    Cancer Causes Control. 2018 Apr 17. pii: 10.1007/s10552-018-1029.
    PubMed     Text format     Abstract available


    Cancer Radiother

  9. MOHAMED HAH, Salem MA, Elnaggar MS, Gabr A, et al
    Trimodalities for bladder cancer in elderly: Transurethral resection, hypofractionated radiotherapy and gemcitabine.
    Cancer Radiother. 2018 Apr 17. pii: S1278-3218(18)30042.
    PubMed     Text format     Abstract available


    CMAJ

  10. ROHAILLA S, Kitchlu A, Wheatcroft M, Razak F, et al
    Mycotic aneurysm formation after bacillus Calmette-Guerin instillation for recurrent bladder cancer.
    CMAJ. 2018;190:E467-E471.
    PubMed     Text format    


    Drug Des Devel Ther

  11. LYU L, Huang LQ, Huang T, Xiang W, et al
    Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
    Drug Des Devel Ther. 2018;12:743-756.
    PubMed     Text format     Abstract available


    EBioMedicine

  12. WU SX, Huang J, Liu ZW, Chen HG, et al
    A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.
    EBioMedicine. 2018 Mar 31. pii: S2352-3964(18)30121.
    PubMed     Text format     Abstract available


    Gene

  13. WANG X, Wang W, Zhang Q, Gu D, et al
    Tagging SNPs in the HOTAIR gene are associated with bladder cancer risk in a Chinese population.
    Gene. 2018 Apr 16. pii: S0378-1119(18)30408-6. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  14. DEININGER S, Hennenlotter J, Rausch S, Docktor K, et al
    No influence of smoking status on the performance of urine markers for the detection of bladder cancer.
    J Cancer Res Clin Oncol. 2018 Apr 19. pii: 10.1007/s00432-018-2639.
    PubMed     Text format     Abstract available


    J Geriatr Oncol

  15. RACIOPPI M, Di Gianfrancesco L, Ragonese M, Palermo G, et al
    The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients.
    J Geriatr Oncol. 2018 Apr 16. pii: S1879-4068(18)30133.
    PubMed     Text format     Abstract available


    J Urol

  16. CHANG SS
    Re: Intravesical rAd-IFNalpha/Syn3 for Patients with High-Grade, bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
    J Urol. 2018;199:1110-1111.
    PubMed     Text format    

  17. CHANG SS
    Re: Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.
    J Urol. 2018;199:1111-1112.
    PubMed     Text format    

  18. ATALA A
    Re: Evasion of Immunosurveillance by Genomic Alterations of PPARgamma/RXRalpha in Bladder Cancer.
    J Urol. 2018;199:1115-1116.
    PubMed     Text format    


    Med Sci Monit

  19. GUO J, Hu J, Cao R, Chen Q, et al
    Androgen Receptor Is Inactivated and Degraded in Bladder Cancer Cells by Phenyl Glucosamine via miR-449a Restoration.
    Med Sci Monit. 2018;24:2294-2301.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  20. LUO Y, Shi X, Li W, Mo L, et al
    Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder.
    Medicine (Baltimore). 2018;97:e0351.
    PubMed     Text format     Abstract available


    Oncol Rep

  21. CHEN D, Xu J, Zhang Q
    Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies.
    Oncol Rep. 2018 Apr 5. doi: 10.3892/or.2018.6359.
    PubMed     Text format     Abstract available


    Oncotarget

  22. NAIKI T, Naiki-Ito A, Iida K, Etani T, et al
    GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis.
    Oncotarget. 2018;9:15847-15859.
    PubMed     Text format     Abstract available


    Prog Urol

  23. JUNGELS C, Martinez Chanza N, Albisinni S, Mercier M, et al
    Interest of next-generation sequencing in BCG-treated high-risk bladder cancer.
    Prog Urol. 2018 Apr 16. pii: S1166-7087(18)30082.
    PubMed     Text format     Abstract available


    Radiologe

  24. JULIUS D, Geerdes Fenge HF, Weber MA
    [Dyspnea after instillation therapy for bladder cancer].
    Radiologe. 2018 Apr 19. pii: 10.1007/s00117-018-0382.
    PubMed     Text format    


    Scand J Urol

  25. SJOSTROM C, Thorstenson A, Strock V, Hosseini-Aliabad A, et al
    Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer.
    Scand J Urol. 2018 Apr 20:1-8. doi: 10.1080/21681805.2018.1462254.
    PubMed     Text format     Abstract available


    Talanta

  26. AZEVEDO R, Soares J, Gaiteiro C, Peixoto A, et al
    Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.
    Talanta. 2018;184:347-355.
    PubMed     Text format     Abstract available


    Technol Cancer Res Treat

  27. JIANG X, Lei T, Zhang M
    Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer.
    Technol Cancer Res Treat. 2018;17:1533034618769413.
    PubMed     Text format     Abstract available


    Toxicol Sci

  28. LIN YC, Chen WJ, Huang CY, Shiue HS, et al
    Polymorphisms of Arsenic (+3 oxidation state) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer.
    Toxicol Sci. 2018 Apr 14. pii: 4970754. doi: 10.1093.
    PubMed     Text format     Abstract available


    Urol Clin North Am

  29. AVULOVA S, Chang SS
    Role and Indications of Organ-Sparing "Radical" Cystectomy: The Importance of Careful Patient Selection and Counseling.
    Urol Clin North Am. 2018;45:199-214.
    PubMed     Text format     Abstract available

  30. TYSON MD 2ND, Barocas DA
    Quality of Life After Radical Cystectomy.
    Urol Clin North Am. 2018;45:249-256.
    PubMed     Text format     Abstract available

  31. CAMPBELL JG, Smelser WW, Lee EK
    Contemporary Preoperative and Intraoperative Management of the Radical Cystectomy Patient.
    Urol Clin North Am. 2018;45:169-181.
    PubMed     Text format     Abstract available

  32. MAY D, Gills J, Delacroix SE Jr.
    Robotic Cystectomy.
    Urol Clin North Am. 2018;45:183-188.
    PubMed     Text format     Abstract available

  33. REDDY M, Kader K
    Follow-up Management of Cystectomy Patients.
    Urol Clin North Am. 2018;45:241-247.
    PubMed     Text format     Abstract available


    Urologe A

  34. OLBERT P, Goebell PJ, Hegele A
    [Follow-up of bladder cancer : The right examinations at the right time].
    Urologe A. 2018 Apr 16. pii: 10.1007/s00120-018-0641.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: